| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/01/2005 | CN1203850C Effervescent vitamin C granule and its preparation method |
| 06/01/2005 | CN1203849C Remedy for keratoconjunctival diseases |
| 06/01/2005 | CN1203848C P-ethyl phenol aminophenol anal injection for children and its preparationn method |
| 06/01/2005 | CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
| 06/01/2005 | CN1203846C Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| 06/01/2005 | CN1203845C Pharmaceutical composition comprising profen |
| 06/01/2005 | CN1203844C Solid themoformable pharmaceutical composition for the controlled release of ivabradine |
| 06/01/2005 | CN1203843C Preparation method of high-content oil-soluble vitamin slow-releasing microcapsule powder |
| 06/01/2005 | CN1203842C Arificial tear solution |
| 06/01/2005 | CN1203841C Effervescent base |
| 06/01/2005 | CA2488593A1 High lipid content sprayable emulsions |
| 05/31/2005 | US6901293 System and method for monitoring power source longevity of an implantable medical device |
| 05/31/2005 | US6900264 Liquid crystal polymer selected from a homo- or copolymers of polybenzothiazoles, polybenzimidazoles or polybenzoxazoles; in-situ polymerization in the presence of the carbon nanotubes; high strength fibers |
| 05/31/2005 | US6900241 Compositions for, and methods of, treating atherosclerosis |
| 05/31/2005 | US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer |
| 05/31/2005 | US6900198 Salen-metal complexes having superoxide activity, catalase activity, and/or peroxidase activity to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide |
| 05/31/2005 | US6900188 Using polysaccharide macromolecules |
| 05/31/2005 | US6899899 Rapidly disintegrable pharmaceutical composition |
| 05/31/2005 | US6899898 Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 05/31/2005 | US6899897 Comprises benzoin gum, fungicidal clotrimazole, and ethanol; for treatment of athelete's foot, eczema, seborrheic dermatitis and psoriasis |
| 05/31/2005 | US6899896 Hydrogel-driven layered drug dosage form |
| 05/31/2005 | US6899894 Mixture of oestradiol and norethisterone acetate applied to backing with pressure sensitive adhesive; protective coatings; multilayer |
| 05/31/2005 | US6899893 Method for treating an allergic or inflammatory disease |
| 05/31/2005 | US6899890 Bioadhesive drug delivery system |
| 05/31/2005 | US6899887 Controlling supply; insert capsules |
| 05/31/2005 | US6899874 Method for the treatment of bacterial vaginal infections |
| 05/31/2005 | US6899868 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 05/31/2005 | US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 05/31/2005 | US6899863 Method for preparing membrane vesicles |
| 05/31/2005 | US6899840 Process for making pre-formed objects |
| 05/31/2005 | US6899700 Therapeutic agent delivery tampon |
| 05/31/2005 | US6899099 Method for treating a respiratory disease |
| 05/31/2005 | CA2216623C Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
| 05/31/2005 | CA2137595C Treating hormone-dependent conditions |
| 05/31/2005 | CA2127352C Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it |
| 05/26/2005 | WO2005047339A1 Biodegradable oxidized cellulose esters and their uses as microspheres |
| 05/26/2005 | WO2005047323A1 Dry recombinant human alpha 1-antitrypsin formulation |
| 05/26/2005 | WO2005047231A1 Non-symmetrical gelling agent |
| 05/26/2005 | WO2005047218A1 Process for producing 1-octene from butadiene in the presence of titanium catalysts |
| 05/26/2005 | WO2005046749A1 Nanotube treatments for internal medical devices |
| 05/26/2005 | WO2005046728A1 Polysaccharide-containing composition and tear film stabilizing ophthalmic solution |
| 05/26/2005 | WO2005046727A2 Ibuprofen-containing soft gelatin capsules |
| 05/26/2005 | WO2005046707A1 Pharmaceutical compositions including low dosages of desmopressin |
| 05/26/2005 | WO2005046700A1 Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| 05/26/2005 | WO2005046699A1 Freeze-dried article containing prostaglandin |
| 05/26/2005 | WO2005046697A1 Sustained-release phenylalanine derivative preparation for oral administration |
| 05/26/2005 | WO2005046696A1 Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative |
| 05/26/2005 | WO2005046690A1 Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative |
| 05/26/2005 | WO2005046684A1 Once daily dosage forms of trospium |
| 05/26/2005 | WO2005046680A1 Percutaneous absorption type cerebral protective agent |
| 05/26/2005 | WO2005046671A1 Method for preparing submicron particles of paclitaxel |
| 05/26/2005 | WO2005046669A1 Treatment and prevention of liver disease associated with parenteral nutrition (pn) |
| 05/26/2005 | WO2005046663A1 Compositions of quaternary ammonium containing bioavailability enhancers |
| 05/26/2005 | WO2005046655A1 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
| 05/26/2005 | WO2005046654A1 Antiphlogistic and analgesic plaster comprising piroxicam compound |
| 05/26/2005 | WO2005046653A1 Antiphlogistic and analgesic plaster comprising felbinac compound |
| 05/26/2005 | WO2005046652A1 Controlled release ketoprofen formulation |
| 05/26/2005 | WO2005046651A1 Liquid filled capsules of doxycycline |
| 05/26/2005 | WO2005046649A2 Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances |
| 05/26/2005 | WO2005046648A1 Extended release pharmaceutical dosage forms comprising alpha-2 agonist tizanidine |
| 05/26/2005 | WO2005046647A1 Low-dose tablets having a network of polymers |
| 05/26/2005 | WO2005046646A2 Blister pack and solid dosage form comprising desmopressin |
| 05/26/2005 | WO2005046645A1 Microparticles comprising somatostatin analogues |
| 05/26/2005 | WO2005046644A1 Solid amorphous dispersions of an mtp inhibitor for treatment of obesity |
| 05/26/2005 | WO2005046643A2 Method for drug loading in liposomes |
| 05/26/2005 | WO2005046642A1 Compositions of lipids and cationic peptides |
| 05/26/2005 | WO2005046641A2 Compositions and methods for treating a posterior segment of an eye |
| 05/26/2005 | WO2005046640A2 Multi-site drug delivery platform |
| 05/26/2005 | WO2005046639A2 Modular imbibition rate reducer for use with implantable osmotic pump |
| 05/26/2005 | WO2005046637A2 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 05/26/2005 | WO2005046636A1 Dry powder formulations |
| 05/26/2005 | WO2005046635A2 Method for producing multiple emulsions that are stable in storage |
| 05/26/2005 | WO2005046634A2 Gastric juice-resistant form of administration |
| 05/26/2005 | WO2005046572A2 Targeted delivery of controlled release polymer systems |
| 05/26/2005 | WO2005046569A2 Pharmaceutical compositions for the treatment of sars |
| 05/26/2005 | WO2005046567A2 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same |
| 05/26/2005 | WO2005046566A2 Stable gabapentin containing composition |
| 05/26/2005 | WO2005046561A2 Multilayer dosage form comprising a matrix that influences release of a modulatory substance |
| 05/26/2005 | WO2005046316A2 Bovine germicide application device |
| 05/26/2005 | WO2005037341A3 Small particle aerosol liposomes for delivery of anti-cancer drugs |
| 05/26/2005 | WO2005032524A3 Osmotically driven active agent delivery device providing an ascending release profile |
| 05/26/2005 | WO2005025549A3 Multi-layer transdermal drug delivery device |
| 05/26/2005 | WO2005023223A3 Orally administrable dosage form for poorly soluble acids and amphoteric active ingredients |
| 05/26/2005 | WO2005020959A3 Novel drug compositions and dosage forms of topiramate |
| 05/26/2005 | WO2005020901A3 Delivery of a therapeutic agent in a formulation for reduced toxicity |
| 05/26/2005 | WO2005013957A3 Solid dispersible and/or orodispersible non-filmy containing at least one type of active substance pharmaceutical composition and method for the preparation thereof |
| 05/26/2005 | WO2005012488A3 Compositions for encapsulation and controlled release |
| 05/26/2005 | WO2005009411B1 Particles containing an active agent in the form of a co-precipitate |
| 05/26/2005 | WO2005007082A3 Treatment of chronic bacterial infection |
| 05/26/2005 | WO2005005954A3 Method, composition and kit for detecting phosphatidylserine (ps) on cell membranes |
| 05/26/2005 | WO2004112695B1 Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| 05/26/2005 | WO2004110603A3 Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions |
| 05/26/2005 | WO2004108162B1 Controlled release pharmaceutical composition |
| 05/26/2005 | WO2004105725A3 Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer |
| 05/26/2005 | WO2004098524A3 Lipid platinum complexes and methods of use thereof |
| 05/26/2005 | WO2004091538B1 Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
| 05/26/2005 | WO2004083392A3 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 05/26/2005 | WO2004062604A3 Treatment of cancer with 2-deoxyglucose |
| 05/26/2005 | WO2004047797A3 Crystallization method and apparatus using an impinging plate assembly |
| 05/26/2005 | WO2004042068A3 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |